Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30206508 | 0.91 | TAAR1 (0.53) | TAAR1 | |
| SCHEMBL30206519 | 0.84 | TAAR1 (0.52) | TAAR1 | |
| SCHEMBL631422 | 0.81 | TAAR1 (0.71) | TAAR1 | |
| SCHEMBL30206452 | 0.80 | TAAR1 (0.52) | TAAR1 | |
| SCHEMBL30206527 | 0.79 | TAAR1 (0.56) | TAAR1 | |
| SCHEMBL30206515 | 0.76 | TAAR1 (0.53) | TAAR1 | |
| SCHEMBL30206356 | 0.76 | TAAR1 (0.52) | TAAR1 | |
| SCHEMBL30206497 | 0.75 | TAAR1 (0.51) | TAAR1 | |
| SCHEMBL3952576 | 0.75 | TAAR1 (0.60) | TAAR1 | |
| SCHEMBL30206461 | 0.74 | TAAR1 (0.58) | TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132123-A1 | ABAD INHIBITOR COMPOUNDS | UNIV COURT OF THE UNIV OF ST ANDREWS (GB) | 2026-05-14 | — | — | US | disclosed |
| EP-4392412-A1 | ABAD INHIBITOR COMPOUNDS | University Court of The University of St Andrews (GB) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023026060-A1 | ABAD INHIBITOR COMPOUNDS | UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS (GB) | 2023-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132123-A1 | ABAD INHIBITOR COMPOUNDS | ADH1C, ADH1A, CBR1 | TAAR1 676/4885TSHR 4420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.